MRNA Moderna
Nasdaq · SEC CIK 1682852 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $64.63M 14 sales by 6 insiders
- Filings on record
- 574 since 2021-07-02, latest 2026-09-16 16:48
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Bancel Stephane | CEO, Dir | — | $28.72M |
| Hoge Stephen | Pres | — | $28.43M |
| Mock James M | CFO | — | $4.69M |
| Klinger Shannon Thyme | CLO | — | $1.39M |
| AFEYAN NOUBAR | Dir | — | $1.14M |
| Hussain Abbas | Dir | — | $278.9K |
| Horning Sandra | Dir | — | — |
| NABEL ELIZABETH G | Dir | — | — |
| Rubenstein David M. | Dir | — | — |
| Nader Francois | Dir | — | — |
Transactions 1,002
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-07-09 | 2024-07-08 | MRNA | Mock James M | CFO | S - Sale+OE | $118.24 | -689 | 7,269 | -9% | -$81.5K |
| D | 2024-07-09 | 2024-07-05 | MRNA | Mock James M | CFO | M - OptEx | — | +1,452 | 7,958 | +22% | — |
| MT | 2024-06-28 | 2024-06-26 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $127.22 | -15.0K | 2.29M | -0.7% | -$1.91M |
| MT | 2024-06-21 | 2024-06-18 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $133.57 | -15.0K | 2.30M | -0.6% | -$2.00M |
| 2024-06-18 | 2024-06-17 | MRNA | Hoge Stephen | Pres | S - Sale | $138.16 | -15.0K | 1.46M | -1% | -$2.07M | |
| 2024-06-17 | 2024-06-14 | MRNA | Bancel Stephane | CEO, Dir | J - Other | $0.00 | +26.8K | 5.49M | +0.5% | $0 | |
| MT | 2024-06-14 | 2024-06-12 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $147.20 | -15.0K | 2.32M | -0.6% | -$2.21M |
| MI | 2024-06-11 | 2024-06-11 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $148.33 | -202.8K | 1.53M | -12% | -$30.09M |
| DM | 2024-06-11 | 2024-06-07 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +10.2K | 21.1K | +94% | — |
| D | 2024-06-11 | 2024-06-10 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $148.09 | -5,178 | 15.9K | -25% | -$766.8K |
| MT | 2024-06-07 | 2024-06-05 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $151.25 | -15.0K | 1.95M | -0.8% | -$2.27M |
| D | 2024-06-04 | 2024-05-31 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +232 | 11.0K | +2% | — |
| D | 2024-06-04 | 2024-06-03 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $140.72 | -122 | 10.9K | -1% | -$17.2K |
| D | 2024-06-04 | 2024-06-03 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $140.72 | -339 | 1.47M | -0.0% | -$47.7K |
| D | 2024-06-04 | 2024-05-31 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +651 | 1.47M | +0.0% | — |
| D | 2024-06-04 | 2024-05-31 | MRNA | Mock James M | CFO | M - OptEx | — | +1,326 | 7,197 | +23% | — |
| D | 2024-06-04 | 2024-06-03 | MRNA | Mock James M | CFO | S - Sale+OE | $140.72 | -691 | 6,506 | -10% | -$97.2K |
| MT | 2024-05-31 | 2024-05-29 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $145.08 | -20.0K | 1.98M | -1% | -$2.90M |
| D | 2024-05-30 | 2024-05-28 | MRNA | Mock James M | CFO | M - OptEx | — | +328 | 6,054 | +6% | — |
| D | 2024-05-30 | 2024-05-29 | MRNA | Mock James M | CFO | S - Sale+OE | $144.50 | -183 | 5,871 | -3% | -$26.4K |
| D | 2024-05-30 | 2024-05-28 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +328 | 11.0K | +3% | — |
| D | 2024-05-30 | 2024-05-29 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $144.50 | -183 | 10.8K | -2% | -$26.4K |
| D | 2024-05-30 | 2024-05-28 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +610 | 1.47M | +0.0% | — |
| D | 2024-05-30 | 2024-05-29 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $144.50 | -341 | 1.47M | -0.0% | -$49.3K |
| D | 2024-05-29 | 2024-05-28 | MRNA | Mock James M | CFO | S - Sale+OE | $162.47 | -648 | 5,726 | -10% | -$105.3K |
| D | 2024-05-29 | 2024-05-24 | MRNA | Mock James M | CFO | M - OptEx | — | +1,326 | 6,374 | +26% | — |
| D | 2024-05-29 | 2024-05-28 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $162.47 | -1,296 | 10.6K | -11% | -$210.6K |
| D | 2024-05-29 | 2024-05-24 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +2,652 | 11.9K | +29% | — |
| MT | 2024-05-24 | 2024-05-22 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $157.57 | -15.0K | 1.99M | -0.7% | -$2.36M |
| 2024-05-17 | 2024-05-15 | MRNA | Hoge Stephen | Pres | S - Sale | $127.49 | -15.0K | 1.47M | -1% | -$1.91M | |
| MT | 2024-05-17 | 2024-05-15 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $127.33 | -15.0K | 2.00M | -0.7% | -$1.91M |
| D | 2024-05-13 | 2024-05-10 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $120.96 | -255 | 1.49M | -0.0% | -$30.8K |
| D | 2024-05-13 | 2024-05-09 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +522 | 1.49M | +0.0% | — |
| MT | 2024-05-10 | 2024-05-08 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $121.68 | -15.0K | 2.01M | -0.7% | -$1.83M |
| D | 2024-05-07 | 2024-05-03 | MRNA | NABEL ELIZABETH G | Dir | M - OptEx | — | +732 | 2,105 | +53% | — |
| D | 2024-05-07 | 2024-05-03 | MRNA | Berenson Stephen | Dir | M - OptEx | — | +732 | 22.2K | +3% | — |
| MT | 2024-05-03 | 2024-05-01 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $110.92 | -15.0K | 2.03M | -0.7% | -$1.66M |
| MT | 2024-04-26 | 2024-04-24 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $108.32 | -15.0K | 2.04M | -0.7% | -$1.62M |
| MT | 2024-04-19 | 2024-04-17 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $103.38 | -15.0K | 2.06M | -0.7% | -$1.55M |
| 2024-04-16 | 2024-04-15 | MRNA | Hoge Stephen | Pres | S - Sale | $105.02 | -15.0K | 1.49M | -1.0% | -$1.58M | |
| MT | 2024-04-12 | 2024-04-10 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $107.12 | -15.0K | 2.08M | -0.7% | -$1.61M |
| D | 2024-04-09 | 2024-04-05 | MRNA | Mock James M | CFO | M - OptEx | — | +1,453 | 5,753 | +34% | — |
| D | 2024-04-09 | 2024-04-08 | MRNA | Mock James M | CFO | S - Sale+OE | $101.93 | -705 | 5,048 | -12% | -$71.9K |
| MT | 2024-04-05 | 2024-04-03 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $101.68 | -15.0K | 2.10M | -0.7% | -$1.53M |
| MT | 2024-03-29 | 2024-03-27 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $109.06 | -15.0K | 2.11M | -0.7% | -$1.64M |
| MT | 2024-03-22 | 2024-03-20 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $102.39 | -15.0K | 2.12M | -0.7% | -$1.54M |
| 2024-03-19 | 2024-03-15 | MRNA | Hoge Stephen | Pres | S - Sale | $103.17 | -15.0K | 1.50M | -1.0% | -$1.55M | |
| MT | 2024-03-15 | 2024-03-13 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $108.54 | -15.0K | 2.14M | -0.7% | -$1.63M |
| D | 2024-03-11 | 2024-03-08 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $99.05 | -544 | 9,267 | -6% | -$53.9K |
| D | 2024-03-11 | 2024-03-07 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +1,138 | 9,811 | +13% | — |
| D | 2024-03-05 | 2024-03-04 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $94.34 | -309 | 1.52M | -0.0% | -$29.2K |
| D | 2024-03-05 | 2024-03-01 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +652 | 1.52M | +0.0% | — |
| D | 2024-03-05 | 2024-03-01 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +233 | 8,790 | +3% | — |
| D | 2024-03-05 | 2024-03-04 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $94.34 | -117 | 8,673 | -1% | -$11.0K |
| DM | 2024-03-01 | 2024-02-28 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +4,853 | 1.52M | +0.3% | — |
| D | 2024-03-01 | 2024-02-29 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $94.57 | -2,388 | 1.52M | -0.2% | -$225.8K |
| D | 2024-03-01 | 2024-02-29 | MRNA | Mock James M | CFO | S - Sale+OE | $94.57 | -647 | 4,300 | -13% | -$61.2K |
| D | 2024-03-01 | 2024-02-28 | MRNA | Mock James M | CFO | M - OptEx | — | +1,315 | 4,947 | +36% | — |
| D | 2024-03-01 | 2024-02-29 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $94.57 | -670 | 8,557 | -7% | -$63.4K |
| D | 2024-03-01 | 2024-02-28 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +1,315 | 9,227 | +17% | — |
| 2024-02-23 | 2024-02-22 | MRNA | Hoge Stephen | Pres | S - Sale | $100.00 | -15.0K | 1.51M | -1.0% | -$1.50M | |
| 2024-02-16 | 2024-02-14 | MRNA | Bancel Stephane | CEO, Dir | A - Grant | $0.00 | +56.7K | 5.49M | +1% | $0 | |
| 2024-02-16 | 2024-02-16 | MRNA | Bancel Stephane | CEO, Dir | S - Sale | $88.88 | -26.4K | 5.46M | -0.5% | -$2.34M | |
| 2024-02-16 | 2024-02-16 | MRNA | Hoge Stephen | Pres | S - Sale | $88.88 | -10.5K | 1.53M | -0.7% | -$937.0K | |
| 2024-02-16 | 2024-02-14 | MRNA | Hoge Stephen | Pres | A - Grant | $0.00 | +22.7K | 1.54M | +1% | $0 | |
| D | 2024-02-13 | 2024-02-09 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +522 | 1.52M | +0.0% | — |
| D | 2024-02-13 | 2024-02-12 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $86.23 | -304 | 1.52M | -0.0% | -$26.2K |
| 2024-01-17 | 2024-01-16 | MRNA | Hoge Stephen | Pres | S - Sale | $103.90 | -15.0K | 1.52M | -1.0% | -$1.56M | |
| D | 2024-01-09 | 2024-01-05 | MRNA | Mock James M | CFO | M - OptEx | — | +1,452 | 4,404 | +49% | — |
| D | 2024-01-09 | 2024-01-08 | MRNA | Mock James M | CFO | S - Sale+OE | $109.75 | -772 | 3,632 | -18% | -$84.7K |
| 2023-12-28 | 2023-12-27 | MRNA | Hoge Stephen | Pres | S - Sale | $100.01 | -45.0K | 1.53M | -3% | -$4.50M | |
| D | 2023-12-11 | 2023-12-08 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $79.09 | -563 | 7,912 | -7% | -$44.5K |
| D | 2023-12-11 | 2023-12-07 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +1,139 | 8,475 | +16% | — |
| D | 2023-12-07 | 2023-12-06 | MRNA | Garay Arpa | Chief Commercial Off | S - Sale+OE | $78.34 | -564 | 3,690 | -13% | -$44.2K |
| D | 2023-12-07 | 2023-12-05 | MRNA | Garay Arpa | Chief Commercial Off | M - OptEx | — | +1,141 | 4,254 | +37% | — |
| D | 2023-12-05 | 2023-12-04 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $79.31 | -111 | 7,336 | -1% | -$8,803 |
| D | 2023-12-05 | 2023-12-01 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +232 | 7,447 | +3% | — |
| D | 2023-12-05 | 2023-12-04 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $79.31 | -309 | 1.58M | -0.0% | -$24.5K |
| D | 2023-12-05 | 2023-12-01 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +651 | 1.58M | +0.0% | — |
| D | 2023-11-30 | 2023-11-28 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +2,411 | 1.58M | +0.2% | — |
| D | 2023-11-30 | 2023-11-29 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $79.81 | -1,136 | 1.58M | -0.1% | -$90.7K |
| D | 2023-11-13 | 2023-11-09 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +522 | 1.57M | +0.0% | — |
| D | 2023-11-13 | 2023-11-10 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $68.76 | -263 | 1.57M | -0.0% | -$18.1K |
| MT | 2023-11-03 | 2023-11-01 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $76.00 | -10.0K | 2.15M | -0.5% | -$760.0K |
| MT | 2023-10-27 | 2023-10-25 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $76.99 | -10.0K | 2.16M | -0.5% | -$769.9K |
| MT | 2023-10-13 | 2023-10-11 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $103.30 | -15.0K | 2.17M | -0.7% | -$1.55M |
| D | 2023-10-10 | 2023-10-05 | MRNA | Mock James M | CFO | M - OptEx | — | +5,810 | 5,810 | New | — |
| D | 2023-10-10 | 2023-10-06 | MRNA | Mock James M | CFO | S - Sale+OE | $102.50 | -2,858 | 2,952 | -49% | -$292.9K |
| MT | 2023-10-06 | 2023-10-04 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $102.72 | -15.0K | 2.19M | -0.7% | -$1.54M |
| MT | 2023-09-29 | 2023-09-27 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $98.97 | -10.0K | 2.20M | -0.5% | -$989.7K |
| MT | 2023-09-22 | 2023-09-20 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $104.74 | -15.0K | 2.21M | -0.7% | -$1.57M |
| 2023-09-18 | 2023-09-15 | MRNA | Hoge Stephen | Pres | S - Sale | $112.99 | -15.0K | 1.57M | -0.9% | -$1.69M | |
| M | 2023-09-15 | 2023-09-13 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $109.70 | -15.0K | 2.23M | -0.7% | -$1.65M |
| 2023-09-15 | 2023-09-15 | MRNA | Bancel Stephane | CEO, Dir | J - Other | $0.00 | +17.9K | 5.43M | +0.3% | $0 | |
| D | 2023-09-11 | 2023-09-08 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $107.22 | -557 | 7,215 | -7% | -$59.7K |
| D | 2023-09-11 | 2023-09-07 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +1,138 | 7,772 | +17% | — |
| MT | 2023-09-08 | 2023-09-06 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $107.61 | -15.0K | 1.98M | -0.8% | -$1.61M |
| D | 2023-09-07 | 2023-09-06 | MRNA | Garay Arpa | Chief Commercial Off | S - Sale+OE | $108.40 | -574 | 3,113 | -16% | -$62.2K |
| D | 2023-09-07 | 2023-09-05 | MRNA | Garay Arpa | Chief Commercial Off | M - OptEx | — | +1,140 | 3,687 | +45% | — |
| D | 2023-09-06 | 2023-09-01 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +233 | 6,749 | +4% | — |
Purchase Sale Sale after option exercise All abbreviations